Related Experiment Video
Updated: Jun 25, 2026

Multi-Scale Modification of Metallic Implants With Pore Gradients, Polyelectrolytes and Their Indirect Monitoring In vivo
Published on: July 1, 2013
Dual Growth Factor Release From Collagen Based Multilayer Films on Ti-Surfaces Enhances Periimplant Bone Formation
Philipp Kauffmann1, Susanne Wolfer1, Christina Behrens1
1Department of Oral and Maxillofacial Surgery, George-Augusta-University, Göttingen, Germany.
Dual growth factor release from collagen-based polyelectrolyte multilayer films (PEMs) on titanium implants significantly improved periimplant bone formation and contact. Simultaneous release of bone morphogenetic protein-2 (rhBMP-2) and vascular endothelial growth factor (rhVEGF165) was key for enhanced bone healing.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Orthopedic Research
Background:
- Titanium implants are widely used in orthopedics and dentistry.
- Enhancing periimplant bone formation and vascularization is crucial for implant success.
- Polyelectrolyte multilayer films (PEMs) offer a versatile platform for controlled drug and growth factor delivery.
Purpose of the Study:
- To evaluate the impact of dual growth factor release (rhBMP-2 and rhVEGF165) from PEM-coated titanium implants on bone formation and angiogenesis.
- To investigate the effect of simultaneous versus single growth factor release on periimplant healing in a minipig mandible model.
Main Methods:
- Disc-shaped titanium implants were coated with PEMs loaded with rhBMP-2, rhVEGF165, or both.
- Implants were inserted into minipig mandibles and assessed at 4 and 13 weeks for bone formation, bone-implant contact, and CD31 expression (angiogenesis marker).
- Uncoated and unloaded implants served as controls.
Main Results:
- At 4 weeks, PEMs with VEGF and BMP individually increased CD31 expression, but no significant differences in bone formation or contact were observed.
- At 13 weeks, simultaneous release of rhBMP-2 and rhVEGF165 from PEMs significantly enhanced bone implant contact and bone formation.
- All PEM-coated implants with growth factors showed increased CD31 expression, indicating enhanced angiogenesis.
Conclusions:
- Simultaneous release of rhBMP-2 and rhVEGF165 is necessary for significant improvements in periimplant bone formation and bone-implant contact.
- Both rhVEGF165 and rhBMP-2 enhance angiogenesis (CD31 expression) similarly, without an additive effect from simultaneous release.
More Related Videos
10:23Covalent Binding of BMP-2 on Surfaces Using a Self-assembled Monolayer Approach
Published on: August 26, 2013
09:34Visualizing Angiogenesis by Multiphoton Microscopy In Vivo in Genetically Modified 3D-PLGA/nHAp Scaffold for Calvarial Critical Bone Defect Repair
Published on: September 7, 2017
Related Concept Videos
Bone Remodeling
Regulation of Angiogenesis and Blood Supply
The Bone Matrix